|
|
||||||||||
Partnership
News & Events
February 2013
Ph.D. Program renamed «Molecular and Translational Biomedicine» (MTB): Our Ph.D. program «Systems Biology of Complex Diseases» has been renamed «Molecular and Translational Biomedicine» (MTB). This was decided by the CC-SPMD Executive Committee and approved by the Directors’ Conference of the Life Science Zurich Graduate School. The change of name became absolutely essential, because the research focus of the Competence Center CC-SPMD evolved more and more into molecular and translational biomedicine with projects ranging from basic molecular physiology and pathophysiology to translational sciences. New group leaders who work in this field already joined the CC-SPMD or will join in the near future. Furthermore, the new title ideally reflects the spirit of the education modules of the focus program «The Metabolic Basis of Disease» which is financed via the SNF/CRUS ProDoc Program since 2012.
More about the Ph.D. Program «Molecular and Translational Biomedicine» »»
More News & Events
It is a declared goal of the CC-SPMD
- to actively engage in interactions and collaborations with other investigators in the field beyond the Zurich region, in particular Basel, with the aim to build a national program with international recognition in the area of systems physiology and metabolic diseases
- to set-up collaborations and project-based alliances between it and the pharmaceutical/food industry and with biotech companies
- to raise public consciousness of the ‘metabolic syndrome’ as a health issue
- to work with key constituencies locally, regionally and nationally to fight metabolic diseases
- to develop a professional business hub for cooperation with the Pharma- Food- and Biotech sector to effectively promote the conversion of basic discoveries into innovative products
Roche and CC-SPMD collaborate in diabetes research
An innovative industry/academic partnership - 'Systems Biology of beta-cells' - translates Systems Biology research into improved medicines. Scientists at the CC-SPMD and at Roche are cooperating to find new pathways for diabetes drugs.
More information in the media release.
The University of California, Berkeley, the University of Basel and CC-SPMD collaborate in the LiverX program
The RTD-Project 'LiverX: Systems Biology of Hepatic Insulin Resistance' is funded by SNF/SystemsX.ch and comprises of 15 research groups of ETH, the University of Zurich, the University of Basel and the University of California, Berkeley.
Stadtspital Triemli and CC-SPMD collaborate in adipocyte research
The goal of the research program 'Systems Biology of Adipocytes' is to elucidate the mechanisms and the contribution of deregulated adipocyte differentiation and metabolism pertaining to the development of metabolic disorders.
Wichtiger Hinweis:
Diese Website wird in älteren Versionen von Netscape ohne
graphische Elemente dargestellt. Die Funktionalität der
Website ist aber trotzdem gewährleistet. Wenn Sie diese
Website regelmässig benutzen, empfehlen wir Ihnen, auf
Ihrem Computer einen aktuellen Browser zu installieren. Weitere
Informationen finden Sie auf
folgender
Seite.
Important Note:
The content in this site is accessible to any browser or
Internet device, however, some graphics will display correctly
only in the newer versions of Netscape. To get the most out of
our site we suggest you upgrade to a newer browser.
More
information
